Search In this Thesis
   Search In this Thesis  
العنوان
The Use of Botulinum Toxin as an Adjuvant in Managing Children with chronic Constipation and Obstructed Defecation
الناشر
Facuulty of medicine
المؤلف
El-Shahawy,Mohammad Reda
هيئة الاعداد
باحث / محمد رضا الشهاوي
مشرف / أ.د./ أيمن أحمد طلعت
مشرف / أ.د./ أيمن أحمد البغدادي
مشرف / د./ أحمد بسيوني عرفه
تاريخ النشر
2020
عدد الصفحات
118 P.:.
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
جراحة
تاريخ الإجازة
1/1/2020
مكان الإجازة
جامعة عين شمس - كلية الطب - الجراحة العامة
الفهرس
Only 14 pages are availabe for public view

from 118

from 118

Abstract

Background: Pediatric chronic constipation is a challenging pediatric problem with bad impact on quality of life affecting both the child and family; it is a complex disorder of multifactorial etiology and pathophysiology. The diagnosis of functional defecation disorders is primarily based on history and physical examination. Many symptoms-based systems have been instructed for clarified definitions such as ROME and PACCT criteria. The protocol of management of functional constipation usually includes; disimpaction enemas, feeding regulations, bowel diaries and laxatives.
Objective: To evaluate the effectiveness of adding anal Botox injection to those already followed management plan for pediatric age group suffering from chronic functional constipation.
Patients and Methods: The current study included 40 children (3-12 years) with functional constipation, and obstructed defecation. The study included 45% female members and 55% male ones.
Results: Bowel management program was applied on both groups A and B, with Botulinum toxin injection for group B patients only. Improvement was achieved in 22.5% of children in both groups after 2 months of the management, most of the improved cases were in group B, 15%of all cases in ratio of 2:1 in comparison to group A that formed 7.5%.
Conclusion: At the 6 months follow up, the improvement percentage remained at 7.5% in group A and became 17.5% in group B. It is important to note that at the beginning of the study no subject had a good or excellent Rintala score when evaluated and at the end of the study 10% had good scores and 15% had excellent scores. The good scores were achieved equally by both groups, but group B had higher representation in the excellent scores (5 patients from group and a single patient from group A).